• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table 22Risk of transfusion: darbepoetin versus epoetin—current report, current with trials excluded but in 2006 review, and 2006 review

ComparisonTrialsDarbepoetin NEpoetin NRR (95% CI)I2
Current51,0169891.14 (0.82 to 1.59)43%
Current & Excluded61,0411,0141.16 (0.85 to 1.56)34%
2006 review61,1699891.10 (0.93 to 1.29)48%

CI = confidence interval; RR = relative risk

From: Results

Cover of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment
Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update [Internet].
Comparative Effectiveness Reviews, No. 113.
Grant MD, Piper M, Bohlius J, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.